BACKGROUND: Monoamine dysfunction, particularly of the serotonin system, has been the dominant hypothesis guiding research and treatment development in affective disorders. The majority of research has been performed in midlife depressed adults. The importance of understanding the neurobiology of depression in older adults is underscored by increased rates of mortality and completed suicide and an increased risk of Alzheimer's dementia. To evaluate the dynamic response of the serotonin system, the acute effects of citalopram infusion on cerebral glucose metabolism was measured in depressed older adults and control subjects. The hypothesis was tested that smaller decreases in metabolism would be observed in cortical and limbic regions in depressed older adults relative to control subjects. METHODS: Sixteen depressed older adults and 13 control subjects underwent two resting positron emission tomography (PET) studies with the radiotracer [18F]-2-deoxy-2-fluoro-D-glucose after placebo and citalopram infusions. RESULTS: In control subjects compared with depressed older adults, greater citalopram-induced decreases in cerebral metabolism were observed in the right anterior cingulate, middle temporal (bilaterally), left precuneus, and left parahippocampal gyri. Greater decreases in the depressed older adults than control subjects were observed in left superior and left middle frontal gyri and increases in left inferior parietal lobule, left cuneus, left thalamus, and right putamen. CONCLUSIONS: In depressed older adults relative to control subjects, the cerebral metabolic response to citalopram is blunted in cortico-cortical and cortico-limbic pathways and increased in the left hemisphere (greater decrease interiorly and increases posteriorly). These findings suggest both blunted and compensatory cerebral metabolic responses to citalopram in depressed older adults.
BACKGROUND:Monoamine dysfunction, particularly of the serotonin system, has been the dominant hypothesis guiding research and treatment development in affective disorders. The majority of research has been performed in midlife depressed adults. The importance of understanding the neurobiology of depression in older adults is underscored by increased rates of mortality and completed suicide and an increased risk of Alzheimer's dementia. To evaluate the dynamic response of the serotonin system, the acute effects of citalopram infusion on cerebral glucose metabolism was measured in depressed older adults and control subjects. The hypothesis was tested that smaller decreases in metabolism would be observed in cortical and limbic regions in depressed older adults relative to control subjects. METHODS: Sixteen depressed older adults and 13 control subjects underwent two resting positron emission tomography (PET) studies with the radiotracer [18F]-2-deoxy-2-fluoro-D-glucose after placebo and citalopram infusions. RESULTS: In control subjects compared with depressed older adults, greater citalopram-induced decreases in cerebral metabolism were observed in the right anterior cingulate, middle temporal (bilaterally), left precuneus, and left parahippocampal gyri. Greater decreases in the depressed older adults than control subjects were observed in left superior and left middle frontal gyri and increases in left inferior parietal lobule, left cuneus, left thalamus, and right putamen. CONCLUSIONS: In depressed older adults relative to control subjects, the cerebral metabolic response to citalopram is blunted in cortico-cortical and cortico-limbic pathways and increased in the left hemisphere (greater decrease interiorly and increases posteriorly). These findings suggest both blunted and compensatory cerebral metabolic responses to citalopram in depressed older adults.
Authors: Howard J Aizenstein; Meryl A Butters; Jennifer L Figurski; V Andrew Stenger; Charles F Reynolds; Cameron S Carter Journal: Biol Psychiatry Date: 2005-08-15 Impact factor: 13.382
Authors: G S Smith; C F Reynolds; B Pollock; S Derbyshire; E Nofzinger; M A Dew; P R Houck; D Milko; C C Meltzer; D J Kupfer Journal: Am J Psychiatry Date: 1999-05 Impact factor: 18.112
Authors: Amy D Anderson; Maria A Oquendo; Ramin V Parsey; Matthew S Milak; Carl Campbell; J John Mann Journal: J Affect Disord Date: 2004-11-01 Impact factor: 4.839
Authors: C F Reynolds; M A Dew; E Frank; A E Begley; M D Miller; C Cornes; S Mazumdar; J M Perel; D J Kupfer Journal: Am J Psychiatry Date: 1998-06 Impact factor: 18.112
Authors: C F Reynolds; E Frank; M A Dew; P R Houck; M Miller; S Mazumdar; J M Perel; D J Kupfer Journal: Am J Geriatr Psychiatry Date: 1999 Impact factor: 4.105
Authors: Q Miao; X L Zhao; Q Y Zhang; Z Y Zhang; Y H Guan; H Y Ye; S Zhang; M F Zeng; C T Zuo; Y M Li Journal: AJNR Am J Neuroradiol Date: 2012-05-10 Impact factor: 3.825
Authors: Constantine G Lyketsos; Maria C Carrillo; J Michael Ryan; Ara S Khachaturian; Paula Trzepacz; Joan Amatniek; Jesse Cedarbaum; Robert Brashear; David S Miller Journal: Alzheimers Dement Date: 2011-09 Impact factor: 21.566
Authors: Bochao Cheng; Yajing Meng; Yan Zuo; Yi Guo; Xiuli Wang; Song Wang; Ran Zhang; Wei Deng; Yingkun Guo; Gang Ning Journal: Brain Imaging Behav Date: 2021-01-12 Impact factor: 3.978
Authors: Matthias Brendel; Oliver Pogarell; Guoming Xiong; Andreas Delker; Peter Bartenstein; Axel Rominger Journal: Eur J Nucl Med Mol Imaging Date: 2015-01-29 Impact factor: 9.236
Authors: Mark D Underwood; Suham A Kassir; Mihran J Bakalian; Hanga Galfalvy; J John Mann; Victoria Arango Journal: Int J Neuropsychopharmacol Date: 2011-05-09 Impact factor: 5.176
Authors: Gwenn S Smith; Frederick S Barrett; Jin Hui Joo; Najlla Nassery; Alena Savonenko; Devin J Sodums; Christopher M Marano; Cynthia A Munro; Jason Brandt; Michael A Kraut; Yun Zhou; Dean F Wong; Clifford I Workman Journal: Neurobiol Dis Date: 2017-05-13 Impact factor: 5.996
Authors: Christopher M Marano; Clifford I Workman; Christopher H Lyman; Elisse Kramer; Carol R Hermann; Yilong Ma; Vijay Dhawan; Thomas Chaly; David Eidelberg; Gwenn S Smith Journal: Psychiatry Res Date: 2014-02-01 Impact factor: 3.222